SCHEMBL4155308

SCHEMBL4155308

O=C(c1ccc(O)cc1O)N1CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.61
HSP90AB1 P08238 2/20 0.61
PDK1 Q15118 9/20 0.60
PDK2 Q15119 9/20 0.60
PDK3 Q15120 9/20 0.60
PDK4 Q16654 9/20 0.60
CES2 O00748 1/20 0.52
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
ALDH1A1 P00352 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
TSHR P16473 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4159603 0.98 HSP90AA1 (0.63) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL4147789 0.83 HSP90AB1 (0.58) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL19409984 0.83 HSP90AA1 (0.60) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL31717253 0.81 HSP90AA1 (0.47) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL24340140 0.81 HPGD (0.56) HSP90AA1PDK1PDK2PDK3PDK4
SCHEMBL24340081 0.81 HSP90AA1 (0.54) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL4159615 0.80 HSP90AA1 (0.55) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL26815187 0.79 ALDH1A1 (0.53) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL22622443 0.78 HSP90AA1 (0.51) HSP90AA1HSP90AB1PDK1PDK2PDK3
SCHEMBL2302971 0.78 MAPT (0.68) KDM4EPOLBGAAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US claimed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP claimed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO claimed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP disclosed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HSP90AB1 1/4885PDK1 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.